Oxaliplatin plus S-1 or capecitabine as neoadjuvant or adjuvant chemotherapy for locally advanced gastric cancer with D2 lymphadenectomy: 5-year follow-up results of a phase II−III randomized trial

OBJECTIVE: To compare the effect of neoadjuvant chemotherapy (NACT) with adjuvant chemotherapy (ACT) using oxaliplatin plus S-1 (SOX) or capecitabine (CapeOX) on gastric cancer patients with D2 lymphadenectomy. METHODS: This was a two-by-two factorial randomized phase II−III trial, and registered on...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Kan, Ying, Xiangji, Bu, Zhaode, Wu, Aiwen, Li, Zhongwu, Tang, Lei, Zhang, Lianhai, Zhang, Yan, Li, Ziyu, Ji, Jiafu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232367/
https://www.ncbi.nlm.nih.gov/pubmed/30510363
http://dx.doi.org/10.21147/j.issn.1000-9604.2018.05.05

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232367/
https://www.ncbi.nlm.nih.gov/pubmed/30510363
http://dx.doi.org/10.21147/j.issn.1000-9604.2018.05.05

Ejemplares similares